These complexities are increasing due to:
In addition, highly desired, value-based contracts are hard to operationalize in a standardized and efficient way and patients are becoming more tech advanced than pharma innovators – all of these considerations creating new complexities in delivering an exceptional patient experience
For EVERSANA, Market Access is broader than just payer engagement; it’s getting the right treatment to the right patient at the right time in a consistent and sustained manner, and at an affordable price. We know how to balance stakeholder, provider and patient needs to develop impactful market access strategies and execution – which is critical now more than ever.
Powered by ACTICS by EVERSANA●, our artificial intelligence-powered & machine learning-enabled platform, we help clients drive market access success through:
EVERSANA’s suite of comprehensive market access capabilities include:
The intelligence you need to assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.了解更多
Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.了解更多
Distribution from Day 1 including special logistics for regenerative medicine.了解更多
Get therapies to patients quickly and effectively. We manage inventory, payer relationships, cash flow and wraparound patient service needs.了解更多
Help your patients secure treatments by offering options to manage cost.了解更多
World-class creative and digital teams with deep market access, payer, and healthcare communications expertise,了解更多
The pharma/life sciences pipeline is vibrant, with ongoing innovation bringing new hope to patients and providers across many therapeutic areas. Against the backdrop of rapid scientific advancement in and precision medicine and targeted therapies in primary and specialty care as well as rare and orphan diseases, today’s medicines continue to create immense complexity for all stakeholders — patients, providers and payers.